
Bionano Genomics, Inc. (BNGO) has garnered attention with its Saphyr system, a third-generation optical mapping solution offering quick, high-throughput, long-range genome mapping and structural variation detection capabilities critical for genomic research. The number of installed Saphyr systems reached 259 as of the first quarter of 2023, marking a 47% increase compared to the same period last year.
“We are leveraging our investments in the commercial organization and evidence development to drive adoption of the Saphyr system,” stated Chris Stewart, Bionano’s Chief Financial Officer.